Home › Funds › Foresite Capital Management IV, LLC › CYTK

Foresite Capital Management IV, LLC position in CYTK

CYTOKINETICS INC COM NEW · Health Care

Foresite Capital Management IV, LLC reported holding 714,695 shares of CYTK (CYTOKINETICS INC COM NEW) in its Q2 2026 13F filing — a position valued at US$60.9M, representing 20.98% of its reported portfolio and ranking #2 among its reported holdings. Foresite Capital Management IV, LLC has disclosed CYTK holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)714.70K sh
Reported value held$60.88M
Portfolio Weight20.98%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Foresite Capital Management IV, LLC's CYTK position evolved

Foresite Capital Management IV, LLC first disclosed a stake in CYTK in Q3 2025 at 458,295 shares (US$25.2M). The position peaked in Q2 2026 at 714,695 shares, worth US$60.9M. Across 4 filings, Foresite Capital Management IV, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 714,695 shares valued at US$60.9M — an increase of 211,400 shares quarter over quarter.. Notable position changes include a 42% increase in Q2 2026 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 458.30K $25.19M New
Q4 2025 458.30K $29.12M Hold
Q1 2026 503.30K $33.17M Add
Q2 2026 714.70K $60.88M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC COM NEW) is a Health Care company. 51 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has Foresite Capital Management IV, LLC held CYTK?

Foresite Capital Management IV, LLC has disclosed CYTK holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Foresite Capital Management IV, LLC's current position in CYTK?

As of Q2 2026, Foresite Capital Management IV, LLC holds 714.70K shares of CYTK (CYTOKINETICS INC COM NEW), valued at $60.88M, representing 20.98% of its reported portfolio and ranking #2.

Has Foresite Capital Management IV, LLC been buying or selling CYTK?

In the latest 13F filing (Q2 2026), Foresite Capital Management IV, LLC increased its position in CYTK. The position peaked in Q2 2026 at 714.70K shares.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.